These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 25433685)

  • 1. An overview of metabolomic and proteomic profiling in bipolar disorder and its clinical value.
    Ribeiro HC; Zandonadi FDS; Sussulini A
    Expert Rev Proteomics; 2023; 20(11):267-280. PubMed ID: 37830362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of psychiatric diseases: current status and future prospects.
    Kalia M; Costa E Silva J
    Metabolism; 2015 Mar; 64(3 Suppl 1):S11-5. PubMed ID: 25467847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS/MS Quantitation of HILIC-Enriched
    Atashi M; Reyes CDG; Sandilya V; Purba W; Ahmadi P; Hakim MA; Kobeissy F; Plazzi G; Moresco M; Lanuzza B; Ferri R; Mechref Y
    Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Expression of Proteins Associated with Bipolar Disorder as Identified Using the PeptideShaker Software.
    Seregin AA; Smirnova LP; Dmitrieva EM; Zavialova MG; Simutkin GG; Ivanova SA
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS/MS-Based Proteomics Approach for the Identification of Candidate Serum Biomarkers in Patients with Narcolepsy Type 1.
    Sanni A; Goli M; Zhao J; Wang J; Barsa C; El Hayek S; Talih F; Lanuzza B; Kobeissy F; Plazzi G; Moresco M; Mondello S; Ferri R; Mechref Y
    Biomolecules; 2023 Feb; 13(3):. PubMed ID: 36979356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review and Meta-Analysis on MS-Based Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Bipolar Disorder.
    Rodrigues JE; Martinho A; Santos V; Santa C; Madeira N; Martins MJ; Pato CN; Macedo A; Manadas B
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic Review and Meta-Analysis of Mass Spectrometry Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Schizophrenia.
    Rodrigues JE; Martinho A; Santa C; Madeira N; Coroa M; Santos V; Martins MJ; Pato CN; Macedo A; Manadas B
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the relationship between viral infections and trace elements from a metallomics perspective: implications for COVID-19.
    de Jesus JR; de Araújo Andrade T
    Metallomics; 2020 Dec; 12(12):1912-1930. PubMed ID: 33295922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic challenges in bipolar disorder management: A patient-centered approach.
    Nestsiarovich A; Hurwitz NG; Nelson SJ; Crisanti AS; Kerner B; Kuntz MJ; Smith AN; Volesky E; Schroeter QL; DeShaw JL; Young SS; Obenchain RL; Krall RL; Jordan K; Fawcett J; Tohen M; Perkins DJ; Lambert CG
    Bipolar Disord; 2017 Dec; 19(8):676-688. PubMed ID: 28901625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Hybrid Brain Imaging in Neuropsychiatric Disorders.
    Burhan AM; Marlatt NM; Palaniyappan L; Anazodo UC; Prato FS
    Diagnostics (Basel); 2015 Dec; 5(4):577-614. PubMed ID: 26854172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lucid Proteomics System for top-down biomarker research.
    Jourdain S; Bulman A; Dalmasso E
    Arch Physiol Biochem; 2010; 116(4-5):158-62. PubMed ID: 20507259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid identification of protein biomarkers of Escherichia coli O157:H7 by matrix-assisted laser desorption ionization-time-of-flight-time-of-flight mass spectrometry and top-down proteomics.
    Fagerquist CK; Garbus BR; Miller WG; Williams KE; Yee E; Bates AH; Boyle S; Harden LA; Cooley MB; Mandrell RE
    Anal Chem; 2010 Apr; 82(7):2717-25. PubMed ID: 20232878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MALDI-MS data analysis for disease biomarker discovery.
    Yu W; Wu B; Liu J; Li X; Stone K; Williams KR; Zhao H
    Methods Mol Biol; 2006; 328():199-216. PubMed ID: 16785651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bipolar disorder: recent advances and future trends in bioanalytical developments for biomarker discovery.
    de Jesus JR; de Campos BK; Galazzi RM; Martinez JL; Arruda MA
    Anal Bioanal Chem; 2015 Jan; 407(3):661-7. PubMed ID: 25433685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
    Novikova SI; He F; Cutrufello NJ; Lidow MS
    Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in top-down proteomics for disease biomarker discovery.
    Calligaris D; Villard C; Lafitte D
    J Proteomics; 2011 Jun; 74(7):920-34. PubMed ID: 21477672
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.